, Volume 5, Issue 4, pp 274–277 | Cite as

Pharmacoeconomic Studies on Antibiotics

Current Controversies
  • S. Ragnar Norrby
Leading Article


Borrelia Burgdorferi Pharmacoeconomic Study Economic Science Broad Antibacterial Spectrum Control Randomise Trial Design 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Balfour JA, Fauids D. Oral ciprofloxacin: a pharmacoeconomic evaluation of its use in the treatment of serious infections. PharmacoEconomics 3: 398–421, 1993.PubMedCrossRefGoogle Scholar
  2. Beam Jr TR, Gilbert DN, Kunin CM (Eds). Guidelines for the evaluation of ami-infective drug products. Clinical Infectious Diseases 15(Suppl. 1): S1–S346, 1992Google Scholar
  3. Beam Jr TR, Gilbert DN, Kunin CM (Eds, European Working Party). European guidelines for the clinical evaluation of anti-infective drug products, European Society for Clinical Microbiology and Infectious Diseases, Munich. 1993Google Scholar
  4. Benfield P, Chrisp P. Imipenem/cilastatin: a pharmacoeconomic approach of its use in intra-abdominal infections. PharmacoEconomics 1: 443–459, 1992PubMedCrossRefGoogle Scholar
  5. Davies PG, Malek MM, Parker SE. Pharmacoenonomics of antibacterial treatment. PharmacoEconomics 1: 409–437, 1992CrossRefGoogle Scholar
  6. Norrby SR. Ciprofloxacin in the treatment of acute and chronic osteomyelitis: a review. Scandinavian Journal of Infectious Diseases 60(Suppl.): 74–78, 1988Google Scholar
  7. Norrby SR, Eriksson M, Ottosson E. Imipenem-cilastatin versus gentamicin-clindamycin: a cost effectiveness study. Scandinavian Journal of Infectious Diseases 18: 371–374, 1986PubMedCrossRefGoogle Scholar
  8. Pfister HW, Preac-Mursic V, Wilske B, Schielkc E, Sorget F, et al. Randomized comparison of eetriaxonc and cefotaxime in Lyme borreliosis. Journal of Infectious Diseases 163: 311–318, 1991PubMedCrossRefGoogle Scholar
  9. Stamboulian D, Bonvehi P, Arevalo C, Bologna R, Cassetti I, et al. Antibiotic management of outpatients with endocarditis due to penicillin-susceptible streptococci. Reviews of Infectious Diseases 13(Suppl. 2): S160–S163, 1991PubMedCrossRefGoogle Scholar
  10. Swedish Study Group. Therapy of acute and chronic osteomyelitis with ciprofloxacin. Journal of Antimicrobial Chemotherapy 22: 221–228,1988Google Scholar
  11. US Food and Drug Administration. Guidelines for the clinical evaluation of anti-infective drugs (systemic) (adults and children). Publication No. FDA 77-3040, US Department of Health, Education, and Welfare, Washington, DC, 1977Google Scholar

Copyright information

© Adis International Limited 1994

Authors and Affiliations

  • S. Ragnar Norrby
    • 1
  1. 1.Department of Infectious DiseasesUniversity of Lund, Lund University HospitalLundSweden

Personalised recommendations